A NIH-funded study shows acupuncture treatments significantly reduce chronic low back pain and disability in adults 65 and older compared to usual medical care alone.
Bayer has its first regulatory approval for elinzanetant as a non-hormonal treatment for menopausal symptoms – in the UK – as it chases down a rival therapy from Astellas. The Medicines and Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback